GEHCV GE HEALTHCARE TECHNOLOGIES INC

GE HealthCare introduces easy-to-use, easy-to-learn, easy-to-diagnose Versana Premier multi-purpose ultrasound system

GE HealthCare (Nasdaq: GEHC) today announced the launch of the new Versana Premier™, the latest release within the Versana ultrasound family of reliable, affordable, easy-to-use, and versatile ultrasound systems. Versana Premier offers automation and AI-enabled productivity tools to improve workflow and clinical features designed to enhance clinical efficiency and accuracy, all while delivering an effortless user experience and helping clinicians best meet their patient needs.i The Versana Premier is designed to meet the multi-purpose needs of healthcare professionals across diverse clinical specialties and care areas, including general practice, OBGYN, musculoskeletal (MSK), and cardiology.

“The rising demand for imaging has driven the increasing use of ultrasound in primary care. Ultrasound is emerging as a key tool in these clinical settings, enabling accelerated diagnoses and improving patient outcomes and satisfaction,” said Phil Rackliffe, president and CEO of Ultrasound and Image Guided Therapies, GE HealthCare. “Versana Premier is equipped with advanced automated workflow and productivity tools, including educational resources, that can support these clinicians who are often the frontline of disease identification and diagnosis for their patients.”

With advanced features that are intuitive and innovative, Versana Premier empowers clinicians to deliver high-quality care and accurately make decisions to reach a diagnosis with the greatest of ease. Powered by VisionBoost Architecture and accompanied by high-quality probes, including XDclear technology, first-class display technology and new imaging engine, Versana Premier provides exceptional image quality with faster speed.ii Users can also optimize images while scanning with Whizz, which continuously optimizes imaging in real time, and adjust color display with Whizz Color Flow. Other features to support clinicians in clinical decisions include OBGYN imaging tools, like Whizz RenderLive and V-Live 2.0, to capture 3D/4D imaging to clearly follow the baby’s development.

With its enhanced ergonomics, automated tools, service and support, the latest release of Versana Premier offers advanced features for simplified diagnostics and guaranteed time savings.iii Clinicians can experience up to a 38% faster workflow with Whizz clinical features available on the system.iii Furthermore, AI-powered Whizz LabeI can automate labeling of the right kidney, gallbladder and liver, and the new Whizz Follicle can assist with volume calculations and measurements.

“Versana Premier is remarkably user-friendly and image quality in B-Mode is easy to optimize, making it possible to create amazing images," said Dr. Martin Altersberger, Director of Echo Laboratory, State Hospital Steyr, Austria. "The ultrasound system integrates advanced functions with optimized image quality and educational resources, which can be used in various settings. It can, therefore, adequately support clinicians in a wide range of assessments and diagnoses.”

Versana Premier is the highest-tier ultrasound system in the budget-friendly Versana ultrasound family, powered with smart clinical features and streamlined workflow tools to enhance efficiency and provide optimal care to a wide range of patients every day – all with effortless productivity in mind. Versana Premier is available in key countries around the globe. In the United States, Versana Premier is 510(k) cleared by the U.S. Food and Drug Administration and is currently commercially available, with shipments beginning later this month. For more information on Versana Premier, visit: .

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Follow us on , (formerly Twitter), , , and for the latest news, or visit our website for more information.

i Select features may not be available in all regions

ii Compared to Versana Premier R2

iii GE HealthCare-sponsored usability study, using Whizz. Study was conducted in December 2022. JB24263XX

EN
14/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GE HEALTHCARE TECHNOLOGIES INC

GE HealthCare Technologies Inc.: Building a solid stand-alone track re...

Our credit view of this issuer reflects its strong base of stable, recurring revenues from services and consumables, offset by its competitive market environment.

 PRESS RELEASE

GE HealthCare reports third quarter 2024 financial results

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2024. GE HealthCare President and CEO Peter Arduini said, “In the third quarter, we reported sales and orders growth of 1% globally. Both sales and orders grew in the mid-single digits excluding China, with particular strength in the U.S. across all segments. Pharmaceutical Diagnostics also delivered solid performance, driven by healthy procedure volumes. Ongoing lean initiatives across the organization are delivering better value to patients and customers and hav...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of GE HealthCare Technologies Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 23 October 2024 in which we reassessed the appropriateness of the ratings i...

 PRESS RELEASE

GE HealthCare announces CareIntellect for Oncology, harnessing AI to g...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced CareIntellect for Oncology, a new cloud-first application that brings together multi-modal patient data from disparate systems into a single view, using generative AI to summarize clinical notes and reports. The application also surfaces relevant data allowing care teams to quickly understand disease progression and flag potential deviations from the treatment plan to help the clinician determine potential next steps and inform proactive interventions. The application, which is planned to be available to customers in U.S. ...

 PRESS RELEASE

GE HealthCare Announces AI Innovation Lab Showcasing Five New Research...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced a new AI Innovation Lab, an initiative designed to accelerate early-concept AI innovations within the company. These projects are one part of GE HealthCare’s broader AI and digital strategy, which is focused on integrating AI into medical devices, building AI applications that enhance decision-making across the care journey and disease states, and using AI to support better outcomes and operational efficiencies system-wide. The company’s investment in cloud technology underpins this strategy, providing the computing power ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch